The syndrome of hypoparathyroidism, deafness, and renal anomalies

Endocrine Practice

Volumn 19, Issue 6, 2013, Pages 1035-1042

  Upadhyay, Jagriti ^a   Steenkamp, Devin ^b   Milunsky, Jeff ^c  

^a SAINT VINCENT HOSPITAL   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c Center for Human Genetic Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM PHOSPHATE; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; RECOMBINANT PARATHYROID HORMONE; THIAZIDE DIURETIC AGENT; TRANSCRIPTION FACTOR GATA 3; VITAMIN D; WT1 PROTEIN;

CALCIUM URINE LEVEL; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 22; CLINICAL FEATURE; CONSENSUS; GENE MUTATION; GENETIC COUNSELING; HEARING IMPAIRMENT; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; HYPOPARATHYROIDISM DEAFNESS AND RENAL ANOMALY SYNDROME; KIDNEY MALFORMATION; PERCEPTION DEAFNESS; PHENOTYPE; PROGNOSIS; PROTEIN BINDING; REVIEW; SODIUM RESTRICTION;

FEMALE; GATA3 TRANSCRIPTION FACTOR; HEARING LOSS, SENSORINEURAL; HUMANS; HYPOPARATHYROIDISM; NEPHROSIS; PARATHYROID HORMONE; PROGNOSIS; WT1 PROTEINS; YOUNG ADULT;

EID: 84888858943     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP13050.RA     Document Type: Review

References (50)

1. Barakat AY, D'Albora JB, Martin MM, Jose PA. Familial nephrosis, nerve deafness, and hypoparathyroidism. J Pediatr. 1977;91:61-64.
2. Bilous RW, Murty G, Parkinson DB, et al. Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. N Engl J Med. 1992; 327:1069-1074.
3. Pritchard-Jones K, Fleming S, Davidson D, et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature. 1990;346:194-197.
4. Lichtner P, König R, Hasegawa T, Van Esch H, Meitinger T, Schuffenhauer S. An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the DiGeorge syndrome region on 10p13/14. J Med Genet. 2000;37:33-37.
5. Van Esch H, Groenen P, Nesbit MA, et al. GATA3 haplo-insufficiency causes human HDR syndrome. Nature. 2000;406:419-422.
6. Nesbit MA, Bowl MR, Harding B, et al. Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J Biol Chem. 2004;279:22624-22634.
7. Ali A, Christie PT, Grigorieva IV, et al. Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor. Hum Mol Genet. 2007;16:265-275.
8. Ferraris S, Del Monaco AG, Garelli E, et al. HDR syndrome: a novel "de novo" mutation in GATA3 gene. Am J Med Genet A. 2009;149A:770-775.
9. Nakamura A, Fujiwara F, Hasegawa Y, et al. Molecular analysis of the GATA3 gene in five Japanese patients with HDR syndrome. Endocr J. 2011;58:123-130.
10. Labastie MC, Bories D, Chabret C, Grégoire JM, Chrétien S, Roméo PH. Structure and expression of the human GATA3 gene. Genomics. 1994;21:1-6.
11. Yang Z, Gu L, Romeo PH, et al. Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains. Mol Cell Biol. 1994;14:2201-2212.
12. Patient RK, McGhee JD. The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev. 2002;12:416-422.
13. Debacker C, Catala M, Labastie MC. Embryonic expression of the human GATA-3 gene. Mech Dev. 1999;85: 183-187.
14. Van Esch H, Devriendt K. Transcription factor GATA3 and the human HDR syndrome. Cell Mol Life Sci. 2001;58: 1296-1300.
15. Karunaratne A, Hargrave M, Poh A, Yamada T. GATA proteins identify a novel ventral interneuron subclass in the developing chick spinal cord. Dev Biol. 2002;249:30-43.
16. van Doorninck JH, van Der Wees J, Karis A, et al. GATA-3 is involved in the development of serotonergic neurons in the caudal raphe nuclei. J Neurosci. 1999; 19:RC12.
17. Muroya K, Hasegawa T, Ito Y, et al. GATA3 abnormalities and the phenotypic spectrum of HDR syndrome. J Med Genet. 2001;38:374-380.
18. Van der Wees J, van Looij MA, de Ruiter MM, et al. Hearing loss following Gata3 haploinsufficiency is caused by cochlear disorder. Neurobiol Dis. 2004;16:169-178.
19. Taslipinar A, Kebapcilar L, Kutlu M, et al. HDR syndrome (hypoparathyroidism, sensorineural deafness and renal disease) accompanied by renal tubular acidosis and endocrine abnormalities. Intern Med. 2008;47:1003-1007.
20. Kato Y, Wada N, Numata A, Kakizaki H. Case of hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome associated with nephrocalcinosis and distal renal tubular acidosis. Int J Urol. 2007;14:440-442.
21. Hernández AM, Villamar M, Roselló L, Moreno-Pelayo MA, Moreno F, Del Castillo I. Novel mutation in the gene encoding the GATA3 transcription factor in a Spanish familial case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with female genital tract malformations. Am J Med Genet A. 2007;143:757-762.
22. Adachi M, Tachibana K, Asakura Y, Tsuchiya T. A novel mutation in the GATA3 gene in a family with HDR syndrome (Hypoparathyroidism, sensorineural Deafness and Renal anomaly syndrome). J Pediatr Endocrinol Metab. 2006;19:87-92.
23. Zahirieh A, Nesbit MA, Ali A, et al. Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome. J Clin Endocrinol Metab. 2005;90:24ddd45-2450.
24. Al-Shibli A, Al Attrach I, Willems PJ. Novel DNA mutation in the GATA3 gene in an Emirati boy with HDR syndrome and hypomagnesemia. Pediatr Nephrol. 2011;26:1167-1170.
25. Muroya K, Mochizuki T, Fukami M, et al. Diabetes mellitus in a Japanese girl with HDR syndrome and GATA3 mutation. Endocr J. 2010;57:171-174.
26. Verri A, Maraschio P, Devriendt K, et al. Chromosome 10p deletion in a patient with hypoparathyroidism, severe mental retardation, autism and basal ganglia calcifications. Ann Genet. 2004;47:281-287.
27. Förstl H, Krumm B, Eden S, Kohlmeyer K. What is the psychiatric significance of bilateral basal ganglia mineralization? Biol Psychiatry. 1991;29:827-833.
28. König P. Psychopathological alterations in cases of symmetrical basal ganglia sclerosis. Biol Psychiatry. 1989;25: 459-468.
29. Fisher E, Scambler P. Human haploinsufficiency-one for sorrow, two for joy. Nat Genet. 1994;7:5-7.
30. Cooper MS, Gittoes NJ. Diagnosis and management of hypocalcaemia. BMJ. 2008;336:1298-1302.
31. Hofer AM, Brown EM. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol. 2003;4:530-538.
32. Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008;359:391-403.
33. Porter RH, Cox BG, Heaney D, Hostetter TH, Stinebaugh BJ, Suki WN. Treatment of hypoparathyroid patients with chlorthalidone. N Engl J Med. 1978;298:577-581.
34. Bhadada SK, Bhansali A, Sridhar S, Singh R, Rao S. Do we need sick-day guidelines for hypoparathyroidism? Indian J Endocrinol Metab. 2012;16:489-491.
35. Melis D, Genesio R, Boemio P, et al. Clinical description of a patient carrying the smallest reported deletion involving 10p14 region. Am J Med Genet A. 2012;158A:832-835.
36. Arnos KS. Hereditary hearing loss. N Engl J Med. 1994; 331:469-470.
37. Fukami M, Muroya K, Miyake T, et al. GATA3 abnormalities in six patients with HDR syndrome. Endocr J. 2011;58:117-121.
38. Ohta M, Eguchi-Ishimae M, Ohshima M, et al. Novel dominant-negative mutant of GATA3 in HDR syndrome. J Mol Med (Berl). 2011;89:43-50.
39. Sun Y, Xia W, Xing X, et al. Germinal mosaicism of GATA3 in a family with HDR syndrome. Am J Med Genet A. 2009;149A:776-778.
40. Kobayashi H, Kasahara M, Hino M, et al. A novel heterozygous deletion frameshift mutation of GATA3 in a Japanese kindred with the hypoparathyroidism, deafness and renal dysplasia syndrome. J Endocrinol Invest. 2006; 29:851-853.
41. Chenouard A, Isidor B, Allain-Launay E, Moreau A, Le Bideau M, Roussey G. Renal phenotypic variability in HDR syndrome: glomerular nephropathy as a novel finding. Eur J Pediatr. 2013;172:107-110.
42. Chiu WY, Chen HW, Chao HW, Yann LT, Tsai KS. Identification of three novel mutations in the GATA3 gene responsible for familial hypoparathyroidism and deafness in the Chinese population. J Clin Endocrinol Metab. 2006;91:4587-4592.
43. Saito T, Fukumoto S, Ito N, Suzuki H, Igarashi T, Fujita T. A novel mutation in the GATA3 gene of a Japanese patient with PTH-deficient hypoparathyroidism. J Bone Miner Metab. 2009;27:386-389.
44. Nanba K, Usui T, Nakamura M, et al. A novel GATA3 nonsense mutation in a newly diagnosed adult patient of Hypothyroidism, Deafness, and Renal dysplasia (HDR) syndrome. Endocr Pract. 2013;19:e17-e20.
45. Gaynor KU, Grigorieva IV, Nesbit MA, et al. A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome. J Clin Endocrinol Metab. 2009;94:3897-3904.
46. Mino Y, Kuwahara T, Mannami T, Shioji K, Ono K, Iwai N. Identification of a novel insertion mutation in GATA3 with HDR syndrome. Clin Exp Nephrol. 2005;9:58-61.
47. Hasegawa T, Hasegawa Y, Aso T, et al. HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia) associated with del(10)(p13). Am J Med Genet. 1997; 73:416-418.
48. Fujimoto S, Yokochi K, Morikawa H, et al. Recurrent cerebral infarctions and del(10)(p14p15.1) de novo in HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome. Am J Med Genet. 1999;86:427-429.
49. Moldovan O, Carvalho R, Jorge Z, Medeira A. A new case of HDR syndrome with severe female genital tract malformation: comment on "Novel mutation in the gene encoding the GATA3 transcription factor in a Spanish familial case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with female genital tract malformations" by Hernández et al. Am J Med Genet A. 2011;155A:2329-2330.
50. Benetti E, Murer L, Bordugo A, Andreetta B, Artifoni L. 10p12.1 deletion: HDR phenotype without DGS2 features. Exp Mol Pathol. 2009;86:74-76.